Cargando…

Overlapping Presentations of HELLP Syndrome and COVID-19

INTRODUCTION: Haemolysis, elevated liver enzymes and low platelet count (HELLP) syndrome is a leading cause of maternal mortality. The emergence of coronavirus disease 2019 (COVID-19) has led to challenges in diagnosing HELLP syndrome due to overlapping clinical and laboratory presentations. We repo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tou, Leila C, Wang, Andrew A, Siddiqui, Taha A, Mamone, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586501/
https://www.ncbi.nlm.nih.gov/pubmed/36299845
http://dx.doi.org/10.12890/2022_003540
_version_ 1784813707604262912
author Tou, Leila C
Wang, Andrew A
Siddiqui, Taha A
Mamone, Michael
author_facet Tou, Leila C
Wang, Andrew A
Siddiqui, Taha A
Mamone, Michael
author_sort Tou, Leila C
collection PubMed
description INTRODUCTION: Haemolysis, elevated liver enzymes and low platelet count (HELLP) syndrome is a leading cause of maternal mortality. The emergence of coronavirus disease 2019 (COVID-19) has led to challenges in diagnosing HELLP syndrome due to overlapping clinical and laboratory presentations. We report a case of HELLP syndrome complicated by COVID-19 infection. CASE DESCRIPTION: An otherwise healthy pregnant 31-year-old woman presented with fever, myalgia and headache. She was found to be COVID-positive with laboratory signs of HELLP syndrome. Symptoms and laboratory findings trended toward normal after delivery confirming the diagnosis of HELLP syndrome. DISCUSSION: A prompt diagnosis of HELLP syndrome is essential to avoid maternal and fetal complications. Clinicians should be aware of the similarities in presentation between HELLP syndrome and COVID-19 for timely diagnosis and treatment. LEARNING POINTS: SARS-CoV-2 preferentially binds to ACE2 which is expressed in extrapulmonary tissue including placental tissue. COVID-19, HELLP syndrome and preeclampsia may have similar characteristics including elevated blood pressures, liver dysfunction, cardiopulmonary complaints and hypercoagulability. The temporal relationship of symptomatic improvement with delivery and after delivery may better differentiate HELLP syndrome from COVID-19.
format Online
Article
Text
id pubmed-9586501
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SMC Media Srl
record_format MEDLINE/PubMed
spelling pubmed-95865012022-10-25 Overlapping Presentations of HELLP Syndrome and COVID-19 Tou, Leila C Wang, Andrew A Siddiqui, Taha A Mamone, Michael Eur J Case Rep Intern Med Article INTRODUCTION: Haemolysis, elevated liver enzymes and low platelet count (HELLP) syndrome is a leading cause of maternal mortality. The emergence of coronavirus disease 2019 (COVID-19) has led to challenges in diagnosing HELLP syndrome due to overlapping clinical and laboratory presentations. We report a case of HELLP syndrome complicated by COVID-19 infection. CASE DESCRIPTION: An otherwise healthy pregnant 31-year-old woman presented with fever, myalgia and headache. She was found to be COVID-positive with laboratory signs of HELLP syndrome. Symptoms and laboratory findings trended toward normal after delivery confirming the diagnosis of HELLP syndrome. DISCUSSION: A prompt diagnosis of HELLP syndrome is essential to avoid maternal and fetal complications. Clinicians should be aware of the similarities in presentation between HELLP syndrome and COVID-19 for timely diagnosis and treatment. LEARNING POINTS: SARS-CoV-2 preferentially binds to ACE2 which is expressed in extrapulmonary tissue including placental tissue. COVID-19, HELLP syndrome and preeclampsia may have similar characteristics including elevated blood pressures, liver dysfunction, cardiopulmonary complaints and hypercoagulability. The temporal relationship of symptomatic improvement with delivery and after delivery may better differentiate HELLP syndrome from COVID-19. SMC Media Srl 2022-09-07 /pmc/articles/PMC9586501/ /pubmed/36299845 http://dx.doi.org/10.12890/2022_003540 Text en © EFIM 2022 https://creativecommons.org/licenses/by-nc-nd/4.0/This article is licensed under a Commons Attribution Non-Commercial 4.0 License (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Article
Tou, Leila C
Wang, Andrew A
Siddiqui, Taha A
Mamone, Michael
Overlapping Presentations of HELLP Syndrome and COVID-19
title Overlapping Presentations of HELLP Syndrome and COVID-19
title_full Overlapping Presentations of HELLP Syndrome and COVID-19
title_fullStr Overlapping Presentations of HELLP Syndrome and COVID-19
title_full_unstemmed Overlapping Presentations of HELLP Syndrome and COVID-19
title_short Overlapping Presentations of HELLP Syndrome and COVID-19
title_sort overlapping presentations of hellp syndrome and covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586501/
https://www.ncbi.nlm.nih.gov/pubmed/36299845
http://dx.doi.org/10.12890/2022_003540
work_keys_str_mv AT touleilac overlappingpresentationsofhellpsyndromeandcovid19
AT wangandrewa overlappingpresentationsofhellpsyndromeandcovid19
AT siddiquitahaa overlappingpresentationsofhellpsyndromeandcovid19
AT mamonemichael overlappingpresentationsofhellpsyndromeandcovid19